Your browser doesn't support javascript.
loading
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial.
Kudo, Masatoshi; Finn, Richard S; Qin, Shukui; Han, Kwang-Hyub; Ikeda, Kenji; Piscaglia, Fabio; Baron, Ari; Park, Joong-Won; Han, Guohong; Jassem, Jacek; Blanc, Jean Frederic; Vogel, Arndt; Komov, Dmitry; Evans, T R Jeffry; Lopez, Carlos; Dutcus, Corina; Guo, Matthew; Saito, Kenichi; Kraljevic, Silvija; Tamai, Toshiyuki; Ren, Min; Cheng, Ann-Lii.
Afiliação
  • Kudo M; Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Osaka, Japan. Electronic address: m-kudo@med.kindai.ac.jp.
  • Finn RS; Geffen School of Medicine at UCLA, Santa Monica, CA, USA.
  • Qin S; Nanjing Bayi Hospital, Nanjing, Jiangsu, China.
  • Han KH; Severance Hospital, Yonsei University, Seoul, South Korea.
  • Ikeda K; Toranomon Hospital, Tokyo, Japan.
  • Piscaglia F; University of Bologna, Bologna, Italy.
  • Baron A; California Pacific Medical Center, San Francisco, CA, USA.
  • Park JW; National Cancer Center Korea, Goyang-si, South Korea.
  • Han G; Xijing Hospital, Fourth Military Medical University, Xi'an, China.
  • Jassem J; Medical University of Gdansk, Gdansk, Poland.
  • Blanc JF; University of Bordeaux, Bordeaux, France.
  • Vogel A; Hannover Medical School, Hannover, Germany.
  • Komov D; N N Blokhin Cancer Research Center, Moscow, Russia.
  • Evans TRJ; University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, UK.
  • Lopez C; Marqués de Valdecilla University Hospital, Santander, Spain.
  • Dutcus C; Eisai, Woodcliff Lake, NJ, USA.
  • Guo M; Eisai, Woodcliff Lake, NJ, USA.
  • Saito K; Eisai, Woodcliff Lake, NJ, USA.
  • Kraljevic S; Eisai, Hatfield, UK.
  • Tamai T; Eisai, Woodcliff Lake, NJ, USA.
  • Ren M; Eisai, Woodcliff Lake, NJ, USA.
  • Cheng AL; National Taiwan University Hospital, Taipei, Taiwan.
Lancet ; 391(10126): 1163-1173, 2018 03 24.
Article em En | MEDLINE | ID: mdl-29433850

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Quinolinas / Niacinamida / Carcinoma Hepatocelular / Neoplasias Hepáticas / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Quinolinas / Niacinamida / Carcinoma Hepatocelular / Neoplasias Hepáticas / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Ano de publicação: 2018 Tipo de documento: Article